| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.3 |